CVS Health raises FY26 adjusted EPS view to $7.30-$7.50 from $7.00-$7.20

Consensus $7.16. Raises FY26 cash flow from operations view to at least $9.5B from at least $9B. The company said, “The Company is increasing its full-year 2026 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds.”